AI-Powered Drug Discovery

Building Tomorrow’s Medicines Today - Learn More

Announcements

New success on Pi3kalpha inhibitor IC50, selectivity, and culture Tests,

We have released a new paper on our Covid-19 PLPro inhibitors

Phronesis AI’s Platform “Lime Drug Design™” Beta is now available for public use.

“After reviewing Phronesis AI’s Lime Drug Design™ platform with programmer Will Spagnoli, it’s evident that their innovative AI and coding infrastructure could meaningfully accelerate pharmaceutical development, potentially improving healthcare for a large number of people”
— Gary Bradski

  • This platform represents a game winning opportunity for small and medium sized pharma companies to perform like their large and successful counterparts... ...I have conducted a firsthand evaluation of the Phronesis AI platform with a moderately difficult drug discovery project and I can recommend this technology without reservation.

    Dr. Wayne R, Danter, MD

Item 1 of 3